Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Colchicine

Greece Approves Colchicine for Patients With COVID-19 based on Results of COLCORONA Trial

On Sunday January 24th, Greece approved colchicine, an inexpensive medicine for gout, among other things, to be included in the […]

Greece Approves Colchicine for Patients With COVID-19 based on Results of COLCORONA Trial
1 month ago
Share

Montreal Heart Institute’s COLCORONA Trial Reveals Colchicine Treats Reduces Hospitalization & Death Rates Associated with COVID-19

TrialSite News has followed the COLCORONA trial with interest, reporting recently that the findings were looking promising. Now the sponsor, […]

Montreal Heart Institute’s COLCORONA Trial Reveals Colchicine Treats Reduces Hospitalization & Death Rates Associated with COVID-19
1 month ago
Share

University of Oxford RECOVERY Trial Targeting Hospitalized COVID-19 Patients Now Includes Economical and Widely Available Colchicine

TrialSite recently reported that the independent data monitoring committee recommended to continue the Montreal Heart Institute study investigating the use of […]

University of Oxford RECOVERY Trial Targeting Hospitalized COVID-19 Patients Now Includes Economical and Widely Available Colchicine
3 months ago
Share

Independent Data Monitoring Committee Recommends Continuing COLCORONA Study Indicating Potential of Colchicine

Back in June, TrialSite introduced the COLCORONA study led by the Montreal Heart Institute—a Phase 3 randomized, double-blind, placebo-controlled multicenter trial […]

Independent Data Monitoring Committee Recommends Continuing COLCORONA Study Indicating Potential of Colchicine
3 months ago
Share

UT Southwestern Testing Favipiravir, Colchicine & Monoclonal Antibodies to Find Treatments for Mild to Moderate COVID-19 Cases

UT Southwestern Medical Center researchers are investigating existing, available drugs that could potentially help treat mild to moderate COVID-19 cases. […]

UT Southwestern Testing Favipiravir, Colchicine & Monoclonal Antibodies to Find Treatments for Mild to Moderate COVID-19 Cases
7 months ago
Share

At-Home Decentralized COLCORONA Trial Investigates if Colchicine Keeps COVID-19 Symptoms from Progressing to Reduce Hospitalization & Death

There is presently no available, FDA-approved medicine that can be administered at a patient’s home that can prevent the negative […]

At-Home Decentralized COLCORONA Trial Investigates if Colchicine Keeps COVID-19 Symptoms from Progressing to Reduce Hospitalization & Death
7 months ago
Share

Montreal Heart Institute Investigates if Gout Medicine Can Reduce Rate of Death & Lung Complications Associated with COVID-19

The Montreal Heart Institute recently announced that the independent data monitoring committee (DMC) of a clinical trial, after completing a […]

Montreal Heart Institute Investigates if Gout Medicine Can Reduce Rate of Death & Lung Complications Associated with COVID-19
8 months ago
Share

COLCHICINE-PCI Trial Reveals no Benefit of Colchicine Given Orally Prior to PCI

A clinical investigator from the VA New York Harbor Healthcare System in New York, NY, recently presented results of the […]

COLCHICINE-PCI Trial Reveals no Benefit of Colchicine Given Orally Prior to PCI
1 year ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.